April 24, 2020

Introduction

COVID-19 has challenged our industry to quickly rethink and adapt long-standing methods of conducting clinical trials. Important questions have been raised about access to sites and site resourcing, while companies continue to prioritize patient safety, maintain data integrity and reduce the burden on our health care system — all while pivoting to a new virtual trial environment. At Syneos Health, we have developed a staged approach that can help biopharmaceutical companies of all sizes mitigate the effects of COVID-19 on trials. 

Image or Video 

Download the Full Report Below
Download
Download